Security Snapshot

UNITEDHEALTH GROUP INC - Common Stock (UNH) Institutional Ownership

CUSIP: 91324P102

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

3,240

Shares (Excl. Options)

748,888,080

Price

$330.11

Type / Class
Equity / Common Stock
Symbol
UNH on NYSE
Shares outstanding
910,743,651
Price per share
$270.59
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
748,888,080
Total reported value
$247,189,540,986
% of total 13F portfolios
0.14%
Share change
+14,366,589
Value change
+$4,669,529,923
Number of holders
3,240
Price from insider filings
$270.59
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • UNH - UNITEDHEALTH GROUP INC - Common Stock is tracked under CUSIP 91324P102.
  • 3240 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 3,240 to 150 between Q4 2025 and Q1 2026.
  • Reported value moved from $247,189,540,986 to $385,433,367.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Form 13F

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP 91324P102?
CUSIP 91324P102 identifies UNH - UNITEDHEALTH GROUP INC - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 3,240 institutional investors reported holding 748,888,080 shares of UNITEDHEALTH GROUP INC - Common Stock (UNH). This represents 82% of the company’s total 910,743,651 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of UNITEDHEALTH GROUP INC - Common Stock (UNH) together control 51% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 91,600,260 +1.1% 0.44% $30,238,161,829
BlackRock, Inc. 8.2% 74,743,552 +0.61% 0.42% $24,673,593,995
STATE STREET CORP 5% 45,232,170 +2.5% 0.5% $14,931,591,639
Capital World Investors 2.5% 22,591,042 +3.8% 1% $7,457,722,927
GEODE CAPITAL MANAGEMENT, LLC 2.4% 21,791,590 +0.03% 0.44% $7,175,515,873
PRICE T ROWE ASSOCIATES INC /MD/ 2.1% 18,829,054 +3.7% 0.67% $6,215,660,000
Capital International Investors 2% 18,655,111 +6.6% 0.97% $6,158,733,817
JPMORGAN CHASE & CO 1.9% 17,199,093 -7.3% 0.38% $5,677,593,749
MORGAN STANLEY 1.7% 15,790,095 +3.6% 0.31% $5,212,469,427
WELLINGTON MANAGEMENT GROUP LLP 1.7% 15,688,774 -5% 0.91% $5,179,021,185
NORGES BANK 1.5% 13,256,692 0.47% $4,376,166,596
FMR LLC 1.4% 12,699,042 -7.2% 0.21% $4,192,080,593
BANK OF AMERICA CORP /DE/ 1.1% 9,615,825 -8% 0.23% $3,174,279,997
Dodge & Cox 1% 9,172,769 -3.5% 1.6% $3,028,022,775
Bank of New York Mellon Corp 1% 9,157,234 +18% 0.53% $3,022,894,171
NORTHERN TRUST CORP 0.97% 8,846,910 -2.9% 0.37% $2,920,453,460
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.93% 8,440,352 +4.7% 0.43% $2,786,247,842
ROYAL BANK OF CANADA 0.89% 8,069,092 -1.5% 0.47% $2,663,688,000
Amundi 0.81% 7,356,057 +27% 0.75% $2,428,309,488
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.8% 7,250,848 +5.4% 0.51% $2,393,577,432
ALLIANCEBERNSTEIN L.P. 0.74% 6,715,914 +4.5% 0.7% $2,216,990,371
FRANKLIN RESOURCES INC 0.7% 6,419,703 +10% 0.52% $2,119,208,287
Capital Research Global Investors 0.69% 6,261,798 -52% 0.38% $2,067,084,892
GOLDMAN SACHS GROUP INC 0.68% 6,189,236 +19% 0.29% $2,043,128,717
Legal & General Group Plc 0.67% 6,059,197 -3.2% 0.44% $2,000,201,523

Institutional Holders of UNITEDHEALTH GROUP INC - Common Stock (UNH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,406,927 $385,433,367 -$39,752,984 $270.59 150
2025 Q4 748,888,080 $247,189,540,986 +$4,669,529,923 $330.11 3,240
2025 Q3 733,201,628 $253,192,258,104 -$12,711,237,446 $345.30 3,138
2025 Q2 771,542,028 $240,595,782,361 -$10,571,955,245 $311.97 3,131
2025 Q1 797,598,075 $417,643,400,722 -$5,449,198,502 $523.75 3,567
2024 Q4 806,973,684 $408,449,626,515 -$2,857,547,861 $505.86 3,642
2024 Q3 808,399,065 $472,751,670,791 +$536,968,408 $584.68 3,438
2024 Q2 807,195,884 $410,870,744,205 +$3,698,568,008 $509.26 3,373
2024 Q1 804,409,692 $397,895,565,873 -$3,596,367,294 $494.70 3,353
2023 Q4 811,684,815 $427,337,906,406 +$1,269,099,237 $526.47 3,398
2023 Q3 807,047,993 $407,064,409,089 +$29,840,695 $504.19 3,124
2023 Q2 807,436,870 $388,009,732,260 -$2,012,490,472 $480.64 3,114
2023 Q1 808,474,510 $382,197,287,112 -$4,024,513,372 $472.59 3,088
2022 Q4 820,780,873 $434,962,144,637 +$1,640,479,205 $530.18 3,132
2022 Q3 819,110,695 $413,921,310,921 -$2,861,075,687 $505.04 2,979
2022 Q2 820,943,270 $421,685,534,400 +$3,837,211,427 $513.63 2,942
2022 Q1 819,430,583 $418,020,136,225 -$1,922,096,975 $509.97 2,945
2021 Q4 822,461,953 $412,886,970,243 +$338,188,515 $502.14 2,881
2021 Q3 821,230,329 $321,038,610,215 -$552,649,201 $390.74 2,551
2021 Q2 822,505,331 $329,392,618,180 -$386,283,681 $400.44 2,572
2021 Q1 824,687,305 $306,832,275,208 -$977,228,421 $372.07 2,499
2020 Q4 827,090,816 $289,956,485,062 -$466,235,188 $350.68 2,452
2020 Q3 828,412,014 $258,095,751,488 -$1,380,200,918 $311.77 2,225
2020 Q2 831,401,889 $245,173,503,951 +$946,598,999 $294.95 2,198
2020 Q1 828,591,495 $206,700,628,181 -$902,851,686 $249.38 2,111
2019 Q4 831,497,003 $244,410,496,940 +$4,262,491,701 $293.98 2,141
2019 Q3 817,814,325 $177,746,706,650 -$679,874,128 $217.32 1,919
2019 Q2 820,128,299 $200,149,457,462 +$2,194,054,046 $244.01 1,958
2019 Q1 822,580,784 $203,293,589,344 -$1,650,638,833 $247.26 1,935
2018 Q4 829,024,469 $206,445,174,466 -$232,037,974 $249.12 1,912
2018 Q3 829,653,941 $220,664,130,485 -$342,745,929 $266.04 1,778
2018 Q2 830,811,550 $203,739,016,882 +$1,079,992,301 $245.34 1,748
2018 Q1 826,325,808 $176,862,430,832 -$2,978,243,866 $214.00 1,689
2017 Q4 840,816,264 $185,323,943,437 -$843,645,743 $220.46 1,670
2017 Q3 842,606,387 $165,023,669,677 +$407,639,540 $195.85 1,512
2017 Q2 845,738,353 $156,849,786,642 +$1,526,860,951 $185.42 1,483
2017 Q1 837,434,016 $137,407,667,394 +$12,550,148,227 $164.01 1,444
2016 Q4 829,738,686 $132,829,365,759 -$302,961,073 $160.04 1,409
2016 Q3 828,084,346 $115,891,312,157 +$305,807,048 $140.00 1,268
2016 Q2 825,999,203 $116,641,974,949 -$1,455,277,721 $141.20 1,255
2016 Q1 836,111,755 $107,774,612,079 -$305,615,744 $128.90 1,207
2015 Q4 837,394,016 $98,528,676,253 -$435,724,910 $117.64 1,214
2015 Q3 840,466,263 $97,501,305,016 +$1,394,221,830 $116.01 1,189
2015 Q2 831,731,629 $101,471,885,223 -$317,727,770 $122.00 1,193
2015 Q1 833,208,161 $98,508,478,681 -$1,347,114,778 $118.29 1,152
2014 Q4 847,287,749 $85,693,945,140 -$827,349,531 $101.09 1,097
2014 Q3 853,666,417 $73,636,084,434 -$1,181,179,717 $86.25 964
2014 Q2 866,467,635 $70,841,559,091 -$570,398,183 $81.75 958
2014 Q1 874,780,380 $71,713,477,668 +$628,155,467 $81.99 945

Sponsored